UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 18, 2004
APPLIED DNA SCIENCES, INC.
------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 290519 59-2262718
---------------------------- ----------- -------------------
(State or other jurisdiction Commission (IRS Employer
of Incorporation) File Number Identification No.)
9229 Sunset Boulevard Los Angeles, CA Ste 830 90069
--------------------------------------------- ---------
(Address of principal executive offices) (Zip Code)
Registrant's Telephone Number, including area code: (310) 860-1362
(Former name or former address, if changed since last report.)
Item 5.02 Appointment of Principal Officers
On August 2, 2004, Applied DNA Sciences, Inc. (the "Company") appointed Karin
Lise Klemm to the position of Chief Operating Officer and Secretary. In that
capacity, Ms. Klemm will oversee the day to day operations of the Company. Ms.
Klemm continues to serve as President of Poly Pacific Entertainment, Inc., an
entertainment company based in Beverly Hills, where she began her employ in that
role in August of 1999. Since August of 2003, Ms. Klemm has served as Chief
Executive Officer to Uncensored Music Network, Inc., also an entertainment
company. Previously, from 1997 through 2000, Ms. Klemm was a branch manager of
RH11, an executive search firm in Los Angeles, California.
Item 7.01 Regulation FD Disclosure
On August 18, 2004, the Company mailed a letter to its record shareholders. The
letter referenced specific agreements recently entered into but not yet
announced. Additionally, the letter disclosed the Company's progress in
furthering its business plan. In accordance with Regulation FD, this current
report is being filed to publicly disclose all information that was provided to
the record shareholders of Applied DNA in its August 18th letter. This report
under Item 7.01 is not deemed an admission as to the materiality of any
information in this report that is required to be disclosed solely by Regulation
FD.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits. The following document is filed as an exhibit to this report:
99.1 Letter to record shareholders dated August 18, 2004
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
APPLIED DNA SCIENCES, INC.
/S/ Peter Brockelsby
------------------------------
Peter Brockelsby, President